Design a Comprehensive Learning and Development Leadership Program
As the executive learning and development director for a midsized global petroleum organization, you have been asked by the chief human resources officer (CHRO) to create a report on how you envision the design of a new leadership program for the organization’s 50 management and executives in leadership teams across four different departments: sales, marketing, finance, and engineering. These teams span three countries: the United States, Canada, and Mexico. In your report, please include the elements below.
Include an introductory paragraph with the name of your fictitious company, where the home office is located (you choose this), how long the company has been in business, and some background information. Do not use the name of or information about a real company.
Discuss your leadership development strategy, and give a vision to this strategy. For example, what are the outcomes of having a leadership development program for the organization?
Discuss how you plan to assess leadership capabilities.
Explain two to three assessment tools that you will use to identify leadership capabilities for each department.
Explain two to three leadership development methods for each department, taking into consideration cultures in each region—the United States, Canada, and Mexico.
Then, conclude your report by describing the benefits that a formal leadership development program will have on the organization. For example, explain why a leadership development program is important and how it enhances the organization’s competitiveness.
In order to formulate viable alternatives to the United States current system, we conducted an in-depth research of the different policies of other countries was conducted. Currently, the United States allows for pharmaceutical companies to control costs while many other governments around the world have chosen to do otherwise. Many countries have established single-payer systems or have chosen universal healthcare coverage. By definition, universal healthcare is a system that ensures that everyone has “coverage for basic health care services and no one is denied care as long as he or she remains legal residents in the given territory” (Torrey). On the other hand, single-payer systems refers to one designated body to be in charge of paying health care claims. Although universal health care coverage can be achieved through single-payer systems, it is not a requirement. Countries that currently have universal coverage include France, Denmark, Australia, Ireland, and Israel. Some countries that have single-payer systems include Norway, Japan, the United Kingdom, Sweden, Canada, Finland, and Spain (Montgomery). Table 1 below depicts several examples of the price differences of drugs in several of the countries mentioned.
Table 1. Average drug prices of drugs in USA, Canada, France, and Germany (2015).
For example, Actimmune is a drug used to prevent skin infections in patients with malignant osteoporosis and chronic granulomatous disease. The cost of this injectable medication is $52,321 for 12 vials in the United States while it is priced at $6,897 in the United Kingdom for the same amount (Nawrat). The United Kingdom utilized the single-payer system to implement universal coverage for drugs; therefore, costs are negotiated down to what is deemed appropriate and feasible. Similar to the FDA, the European Commision approves drugs but what makes their system different is that they have a separate body called the National Institute for Health and Social Care Excellence (NICE) who is responsible for deter